Please login to the form below

Not currently logged in
Email:
Password:

INC Research to merge with InVentiv Health

Combined will be second-largest outsourcing provider after QuintilesIMS

INC researchContract research organisation INC Research and commercial services firm InVentiv Health are to combine to create the second largest biopharmaceutical outsourcing provider.

The deal, which is expected to close during the second half of 2017 and values the new at around $7.4bn, comes seven months after the $18bn merger of Quintiles and IMS Health.

The latest service sector megadeal will see INC Research shareholders hold 53% to InVentiv’s 47%.

Once completed INC Research’s chief executive officer Alastair Macdonald will hold the same role in the newly-combined firm, with inVentiv Health’s CEO Michael Bell serving as its executive chairman.

Macdonald said: “Through this strategic combination we are bringing together two of the most innovative and respected players in the field to create a leading global biopharma solutions organisation with a full suite of clinical and commercial solutions to address the needs of biopharmaceutical companies, patients, physicians and payers.”

The new merger intends to create more effective clinical studies, deepen therapeutic expertise in areas such as cardiovascular, metabolic and respiratory diseases, improve access to data assets and partner with biopharmaceutical companies.

Bell said: “The new company is purpose-built to address market realities where clinical and commercial must work together sharing expertise, data and insights to improve clinical performance.

“We believe this merger has significant client advantages as it deepens our scale, scope and therapeutic expertise.”

The organisation will be headquartered in North Carolina, US operating worldwide and the companies will each contribute five directors totalling a board of 10 directors.

Article by
Gemma Jones

11th May 2017

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics